RTI Surgical Holdings, Inc, a surgical implant company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.
Read More…
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
Phone386-418-8888
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$280.86 million
Profitability
Miscellaneous
Employees891
Next Earnings Date10/31/2019 (Confirmed)
OptionableOptionable
RTI Surgical (NASDAQ:RTIX) Frequently Asked Questions
What is RTI Surgical's stock symbol?
RTI Surgical trades on the NASDAQ under the ticker symbol "RTIX."
How were RTI Surgical's earnings last quarter?
RTI Surgical Holdings Inc (NASDAQ:RTIX) released its quarterly earnings data on Thursday, August, 1st. The medical equipment provider reported $0.01 earnings per share for the quarter, beating analysts' consensus estimates of ($0.01) by $0.02. The medical equipment provider earned $82.31 million during the quarter. RTI Surgical had a negative net margin of 1.08% and a positive return on equity of 3.55%. View RTI Surgical's Earnings History.
When is RTI Surgical's next earnings date?
How can I listen to RTI Surgical's earnings call?
RTI Surgical will be holding an earnings conference call on Thursday, October 31st at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What guidance has RTI Surgical issued on next quarter's earnings?
RTI Surgical updated its FY 2019 earnings guidance on Thursday, August, 1st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $325-335 million, compared to the consensus revenue estimate of $325.82 million.
What price target have analysts set for RTIX?
3 Wall Street analysts have issued 1-year target prices for RTI Surgical's stock. Their forecasts range from $5.00 to $8.00. On average, they expect RTI Surgical's share price to reach $6.67 in the next twelve months. This suggests a possible upside of 148.8% from the stock's current price. View Analyst Price Targets for RTI Surgical.
What is the consensus analysts' recommendation for RTI Surgical?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RTI Surgical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for RTI Surgical.
Has RTI Surgical been receiving favorable news coverage?
News articles about RTIX stock have trended somewhat positive on Sunday, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. RTI Surgical earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave news headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for RTI Surgical.
Who are some of RTI Surgical's key competitors?
Some companies that are related to RTI Surgical include Establishment Labs (ESTA), Sientra (SIEN), Invacare (IVC), ConforMIS (CFMS), Lakeland Industries (LAKE), Histogenics (HSGX), Rewalk Robotics (RWLK), COLLPLANT HOLDI/S (CLGN), Precision Therapeutics (POAI), NanoVibronix (NAOV), Wound Management Technologies (WNDM), Allied Healthcare Products (AHPI), Bionik Laboratories (BNKL), Ocugen (OCGN) and Avitar (AVTI).
What other stocks do shareholders of RTI Surgical own?
Who are RTI Surgical's key executives?
RTI Surgical's management team includes the folowing people:
- Mr. Camille I. Farhat, CEO, Pres & Director (Age 49)
- Mr. Jonathon M. Singer, Chief Financial & Admin. Officer and Corp. Sec. (Age 55)
- Mr. John N. Varela, Exec. VP of Global Operations (Age 52)
- Mr. Tony Lemus, VP of Global R&D, Clinical and Regulatory
- Ms. Molly Poarch, Director of Corp. Communications
How do I buy shares of RTI Surgical?
Shares of RTIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is RTI Surgical's stock price today?
One share of RTIX stock can currently be purchased for approximately $2.68.
How big of a company is RTI Surgical?
RTI Surgical has a market capitalization of $198.05 million and generates $280.86 million in revenue each year. The medical equipment provider earns $-1,250,000.00 in net income (profit) each year or $0.12 on an earnings per share basis. RTI Surgical employs 891 workers across the globe.View Additional Information About RTI Surgical.
What is RTI Surgical's official website?
How can I contact RTI Surgical?
RTI Surgical's mailing address is 11621 RESEARCH CIRCLE, ALACHUA FL, 32615. The medical equipment provider can be reached via phone at 386-418-8888 or via email at [email protected]
MarketBeat Community Rating for RTI Surgical (NASDAQ RTIX)
MarketBeat's community ratings are surveys of what our community members think about RTI Surgical and other stocks. Vote "Outperform" if you believe RTIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RTIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
